EBPC
EBPC is a potent aldose reductase inhibitor which inhibits PGF2α production, enhances ERK activity and potentiates anticancer effects of cisplatin and doxorubicin.
| Trivial name | / |
| Catalog Number | CSN13622 |
| Alternative Name(s) | / |
| Research Area | / |
| Molecular Formula | C14H15NO4 |
| CAS# | 4450-98-0 |
| Purity | ≥98% |
| SMILES | O=C(C1=C(O)C(N(CC2=CC=CC=C2)C1)=O)OCC |
| Size | 100mg |
| Supplier Page | https://www.csnpharm.com/products/ebpc.html |